These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27180266)

  • 1. Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladder.
    Naito A; Taguchi S; Nakagawa T; Matsumoto A; Nagase Y; Tabata M; Miyakawa J; Suzuki M; Nishimatsu H; Enomoto Y; Takahashi S; Okaneya T; Yamada D; Tachikawa T; Minowada S; Fujimura T; Fukuhara H; Kume H; Homma Y
    World J Urol; 2017 Jan; 35(1):97-103. PubMed ID: 27180266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical analysis of small cell carcinoma of the bladder in Chinese: nine case reports and literature reviews.
    Chen Z; Liu Q; Chen R; Liu Z; Li M; Ling Q; Wu L; Yang J; Liu X; Wang T; Hu Z; Guo X; Wang S; Yang W; Liu J
    World J Surg Oncol; 2017 Jan; 15(1):33. PubMed ID: 28125986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.
    Fizazi K; Cojean I; Pignon JP; Rixe O; Gatineau M; Hadef S; Arriagada R; Baldeyrou P; Comoy E; Le Chevalier T
    Cancer; 1998 Mar; 82(6):1049-55. PubMed ID: 9506348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy.
    Quoix E; Purohit A; Faller-Beau M; Moreau L; Oster JP; Pauli G
    Lung Cancer; 2000 Nov; 30(2):127-34. PubMed ID: 11086206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-specific enolase and response to initial therapy are important prognostic factors in patients with small cell lung cancer.
    Zhou M; Wang Z; Yao Y; Zhou H; Liu M; Sun J
    Clin Transl Oncol; 2017 Jul; 19(7):865-873. PubMed ID: 28127669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma.
    Zhou HH; Liu LY; Yu GH; Qu GM; Gong PY; Yu X; Yang P
    Anticancer Res; 2017 Aug; 37(8):4529-4537. PubMed ID: 28739749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prognostic value of serum neuron specific enolase detection in small cell lung cancer].
    Jin B; Zhao L; Zhou C
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Dec; 24(12):722-4. PubMed ID: 11930699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
    Bonner JA; Sloan JA; Rowland KM; Klee GG; Kugler JW; Mailliard JA; Wiesenfeld M; Krook JE; Maksymiuk AW; Shaw EG; Marks RS; Perez EA
    Clin Cancer Res; 2000 Feb; 6(2):597-601. PubMed ID: 10690544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder.
    Meijer RP; Meinhardt W; van der Poel HG; van Rhijn BW; Kerst JM; Pos FJ; Horenblas S; Bex A
    Int J Urol; 2013 Aug; 20(8):778-84. PubMed ID: 23231456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study.
    Cattrini C; Cerbone L; Rubagotti A; Zinoli L; Latocca MM; Messina C; Zanardi E; Boccardo F
    Clin Genitourin Cancer; 2019 Aug; 17(4):e724-e732. PubMed ID: 31160193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.
    Jørgensen LG; Osterlind K; Genollá J; Gomm SA; Hernández JR; Johnson PW; Løber J; Splinter TA; Szturmowicz M
    Br J Cancer; 1996 Aug; 74(3):463-7. PubMed ID: 8695366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of serum neuron-specific enolase in non-small cell lung cancer].
    Kimura H; Yamaguchi T; Nishino K; Nakagawa M; Yokota S; Nishikawa H; Ito M; Ogura T
    Nihon Kokyuki Gakkai Zasshi; 1998 Feb; 36(2):128-32. PubMed ID: 9617138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic factors in patients with small cell lung cancer].
    Song LH; Song XR; Zhang XQ; Qi JL; Li XJ; Tian H; Bu B
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):413-6. PubMed ID: 15355646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends.
    Koay EJ; Teh BS; Paulino AC; Butler EB
    Cancer; 2011 Dec; 117(23):5325-33. PubMed ID: 21567387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?
    Hirose T; Okuda K; Yamaoka T; Ishida K; Kusumoto S; Sugiyama T; Shirai T; Ohnshi T; Ohmori T; Adachi M
    Lung Cancer; 2011 Feb; 71(2):224-8. PubMed ID: 20537424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung.
    Johnson DH; Marangos PJ; Forbes JT; Hainsworth JD; Van Welch R; Hande KR; Greco FA
    Cancer Res; 1984 Nov; 44(11):5409-14. PubMed ID: 6091878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Neuron-Specific Enolase Levels Predict the Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations.
    Suh KJ; Keam B; Kim M; Park YS; Kim TM; Jeon YK; Kim DW; Chung DH; Kim YW; Heo DS
    Clin Lung Cancer; 2016 Jul; 17(4):245-252.e1. PubMed ID: 26719155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of neuron-specific enolase (NSE) and thymidine kinase (TK) levels in prediction of efficacy ofEGFR-TKIs in patients with advanced-stage NSCLC [corrected].
    Fiala O; Pesek M; Finek J; Benesova L; Minarik M; Bortlicek Z; Topolcan O
    Anticancer Res; 2014 Sep; 34(9):5193-8. PubMed ID: 25202114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
    Ando S; Suzuki M; Yamamoto N; Iida T; Kimura H
    Anticancer Res; 2004; 24(3b):1941-6. PubMed ID: 15274381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.